Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
anemic chronic kidney disease
Pharma
Akebia unveils IRA-driven high price for Vafseo
Despite uncertainties around a nondialysis expansion with the FDA, the company has decided to incorporate that indication in Vafseo's price now.
Angus Liu
Jul 11, 2024 10:54am
Akebia's Vafseo wins FDA approval 2 years after rejection
Mar 28, 2024 9:25am
FibroGen CEO Enrique Conterno hits the exit after 3-year stint
Jul 25, 2023 2:02pm
Akebia finds new partner for oral anemia drug in Europe
May 25, 2023 10:56am
Akebia proposes new dosing for oral anemia drug amid FDA dispute
Apr 3, 2023 11:34am
Docs 'cautious' about GSK's new anemia drug: survey
Feb 9, 2023 2:52pm
